Paper42007147
Gypenosides attenuate H2O2-induced oxidative stress in orbital fibroblasts from thyroid-associated ophthalmopathy by activating the Nrf2/ERK/HO-1 signaling pathway.
Ma C and 6 others. Am J Transl Res, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Gypenosides attenuate H2O2-induced oxidative stress in orbital fibroblasts from thyroid-associated ophthalmopathy by activating the Nrf2/ERK/HO-1 signaling pathway. Papers, record 42007147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42007147
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Gypenosides attenuate H2O2-induced oxidative stress in orbital fibroblasts from thyroid-associated ophthalmopathy by activating the Nrf2/ERK/HO-1 signaling pathway.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36157877 | Therapeutic Effect of Gypenosides on Antioxidant Stress Injury in Orbital Fibroblasts of Graves' Orbitopathy. | J Immunol Res | 2022 | https://conductscience.org/library/papers/36157877 | PubMed |
| 2 | 40881120 | Development and validation of a nomogram prediction model for factors influencing 131I-refractory Graves' hyperthyroidism. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/40881120 | PubMed |
| 3 | 39237996 | An L-type calcium channel blocker nimodipine exerts anti-fibrotic effects by attenuating TGF-β1 induced calcium response in an in vitro model of thyroid eye disease. | Eye Vis (Lond) | 2024 | https://conductscience.org/library/papers/39237996 | PubMed |
| 4 | 40853309 | Targeted Delivery of CD34 Aptamer-Coupled Tocilizumab Microspheres for Effective Treatment of Thyroid-Associated Ophthalmopathy. | Invest Ophthalmol Vis Sci | 2025 | https://conductscience.org/library/papers/40853309 | PubMed |
| 5 | 20430828 | PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach. | Nucleic Acids Res | 2010 | https://conductscience.org/library/papers/20430828 | PubMed |
| 6 | 40838840 | Gypenosides Ameliorate Hyperlipidemia by Activating Lipophagy through Modulation of the AMPK/mTOR/ULK1 Signaling Pathway. | J Agric Food Chem | 2025 | https://conductscience.org/library/papers/40838840 | PubMed |
| 7 | 37597078 | Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging. | Arch Toxicol | 2023 | https://conductscience.org/library/papers/37597078 | PubMed |
| 8 | 39313657 | Artemisinin Ameliorates the Neurotoxic Effect of 3-Nitropropionic Acid: A Possible Involvement of the ERK/BDNF/Nrf2/HO-1 Signaling Pathway. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/39313657 | PubMed |
| 9 | 40544935 | Investigating the effects of dendrobine on fibrosis and inflammation in orbital fibroblasts of thyroid-associated ophthalmopathy via network pharmacology, molecular docking, and transcriptomics. | Eur J Pharmacol | 2025 | https://conductscience.org/library/papers/40544935 | PubMed |
| 10 | 36994473 | Molecular Basis of the KEAP1-NRF2 Signaling Pathway. | Mol Cells | 2023 | https://conductscience.org/library/papers/36994473 | PubMed |
| 11 | 26675405 | Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy. | Exp Eye Res | 2016 | https://conductscience.org/library/papers/26675405 | PubMed |
| 12 | 29144836 | Autophagy and Inflammation. | Annu Rev Immunol | 2018 | https://conductscience.org/library/papers/29144836 | PubMed |
| 13 | 24735618 | TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. | J Cheminform | 2014 | https://conductscience.org/library/papers/24735618 | PubMed |
| 14 | 40771890 | Cerium oxide nanoparticles attenuates fibrosis and inflammation in thyroid-associated ophthalmopathy via JNK pathway. | Front Mol Biosci | 2025 | https://conductscience.org/library/papers/40771890 | PubMed |
| 15 | 40736178 | Epac1 Inhibits Orbital Fibroblast Activation to Ameliorate Thyroid-Associated Orbitopathy-Like Features Through the JAK/STAT Signaling Pathway. | Invest Ophthalmol Vis Sci | 2025 | https://conductscience.org/library/papers/40736178 | PubMed |
| 16 | 38100883 | MCL attenuates atherosclerosis by suppressing macrophage ferroptosis via targeting KEAP1/NRF2 interaction. | Redox Biol | 2024 | https://conductscience.org/library/papers/38100883 | PubMed |
| 17 | 28472422 | PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database. | Nucleic Acids Res | 2017 | https://conductscience.org/library/papers/28472422 | PubMed |
| 18 | 39343109 | Gypenosides alleviate oxidative stress in the hippocampus, promote mitophagy, and mitigate depressive-like behaviors induced by CUMS via SIRT1. | J Ethnopharmacol | 2025 | https://conductscience.org/library/papers/39343109 | PubMed |
| 19 | 35709102 | Rituximab for thyroid-associated ophthalmopathy. | Cochrane Database Syst Rev | 2022 | https://conductscience.org/library/papers/35709102 | PubMed |
| 20 | 40807149 | Redefining Treatment Paradigms in Thyroid Eye Disease: Current and Future Therapeutic Strategies. | J Clin Med | 2025 | https://conductscience.org/library/papers/40807149 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42769603 | Wogonoside alleviates ulcerative colitis-induced senescence by activating AMPK in in vivo and in vitro models. | Am J Transl Res | 2026 | https://conductscience.org/library/papers/42769603 |
Source PubMed
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| HMOX1 | 3162 | PubTator's text mining | https://conductscience.org/library/genes/3162 | NCBI Gene |
| MAPK1 | 5594 | PubTator's text mining | https://conductscience.org/library/genes/5594 | NCBI Gene |
| NFE2L2 | 4780 | PubTator's text mining | https://conductscience.org/library/genes/4780 | NCBI Gene |
| SOD1 | 6647 | PubTator's text mining | https://conductscience.org/library/genes/6647 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42007147
GET https://conductscience.org/api/papers/v1/42007147/references?page=2